Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChiang, Jianbangen_US
dc.contributor.authorYuen, Jeanetteen_US
dc.contributor.authorShaw, Tarrynen_US
dc.contributor.authorGoh, Hui Xuanen_US
dc.contributor.authorLi, Shao-Tzuen_US
dc.contributor.authorCourtney, Elizaen_US
dc.contributor.authorNgeow, Joanneen_US
dc.identifier.citationChiang, J., Yuen, J., Shaw, T., Goh, H. X., Li, S.-T., Courtney, E., & Ngeow, J. (2020). Predictive testing for tumor predisposition syndromes in pediatric relatives : an Asian experience. Frontiers in Pediatrics, 8, 568528-. doi:10.3389/fped.2020.568528en_US
dc.description.abstractApproximately 10% of pediatric cancer patients possess germline pathogenic/likely pathogenic variants (PV/LPV) in known tumor predisposition genes. Predictive testing is the optimal approach to identify asymptomatic at-risk relatives to guide gene-directed surveillance for early cancer detection and/or risk-reducing strategies. However, the uptake rate for predictive testing remains low in Asian countries. We aim to evaluate the uptake rate of predictive testing in a pediatric population (aged under 21-years-old) in a multi-ethnic Asian cancer center. Our retrospective analysis included families with PV/LPVs identified in genes associated with pediatric tumor predisposition. Of the 83 pediatric first-degree relatives (FDRs) from 49 unrelated families, 20 FDRs (24.1%) originating from 13 families (26.6%) underwent predictive testing. Genes tested in pediatric FDRs were APC, RB1, SBDS, SDHA, SDHB, SDHD, and TP53. All pediatric FDRs of probands with PV/LPVs in RB1 and biallelic PVs in SBDS underwent predictive testing, while <45% of pediatric FDRs had predictive testing for familial PV/LPVs identified in the APC, SDHA, SDHB, SDHD, and TP53 genes. Amongst the 13 families who underwent pre-test counseling, 80% of pediatric FDRs in these families proceeded with predictive testing. Malay pediatric FDRs and siblings of probands were more likely to undergo predictive testing. We conclude that the predictive testing rate in pediatric FDRs is higher than that of adult FDRs in Asia, but still below the global average. We postulate factors that may influence predictive testing uptake in pediatric FDRs includes a lack of genetics awareness, concerns regarding insurance, and genetic discrimination.en_US
dc.relation.ispartofFrontiers in Pediatricsen_US
dc.rights© 2020 Chiang, Yuen, Shaw, Goh, Li, Courtney and Ngeow. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_US
dc.titlePredictive testing for tumor predisposition syndromes in pediatric relatives : an Asian experienceen_US
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en_US
dc.description.versionPublished versionen_US
dc.subject.keywordsPredictive Testingen_US
item.fulltextWith Fulltext-
Appears in Collections:LKCMedicine Journal Articles
Files in This Item:
File Description SizeFormat 
fped-08-568528.pdf477.14 kBAdobe PDFView/Open

Page view(s)

Updated on Sep 28, 2022

Download(s) 50

Updated on Sep 28, 2022

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.